Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to evaluate pharmacokinetics, pharmacodynamics, safety, radiological and clinical effects of subcutaneous ublituximab in participants wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Ublituximab (ublituximab)

Snippet

Sponsor: TG Therapeutics, Inc. | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: RECRUITING